Literature DB >> 15780600

Kinase signaling cascades that modulate peroxisome proliferator-activated receptors.

Laurent Gelman1, Liliane Michalik, Béatrice Desvergne, Walter Wahli.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors involved in lipid and glucose homeostasis, inflammation and wound healing. In addition to ligand binding, phosphorylation can also regulate PPARs; the biological effects of phosphorylation depend on the stimulus, the kinase, the PPAR isotype, the residue modified, the cell type and the promoter investigated. The study of this dual regulation mode, which allows PPARs to integrate signals conveyed by lipophilic ligands with those coming from the plasma membrane, may ultimately offer new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780600     DOI: 10.1016/j.ceb.2005.02.002

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  24 in total

1.  Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.

Authors:  Emilia Falcetti; Susan M Hall; Peter G Phillips; Jigisha Patel; Nicholas W Morrell; Sheila G Haworth; Lucie H Clapp
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

2.  Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor α.

Authors:  Darren M Gordon; Kari L Neifer; Abdul-Rizaq Ali Hamoud; Charles F Hawk; Andrea L Nestor-Kalinoski; Scott A Miruzzi; Michael P Morran; Samuel O Adeosun; Jeffrey G Sarver; Paul W Erhardt; Robert E McCullumsmith; David E Stec; Terry D Hinds
Journal:  J Biol Chem       Date:  2020-05-13       Impact factor: 5.157

3.  The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.

Authors:  Barbara Bosier; Giulio G Muccioli; Didier M Lambert
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

4.  N-Acetylfarnesylcysteine is a novel class of peroxisome proliferator-activated receptor γ ligand with partial and full agonist activity in vitro and in vivo.

Authors:  Kavita Bhalla; Bor Jang Hwang; Jang Hyun Choi; Ruby Dewi; Lihui Ou; John Mclenithan; William Twaddel; Edwin Pozharski; Jeffry Stock; Geoffrey D Girnun
Journal:  J Biol Chem       Date:  2011-10-06       Impact factor: 5.157

5.  The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α.

Authors:  Eric J Downer; Eileen Clifford; Sylvie Amu; Padraic G Fallon; Paul N Moynagh
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

6.  Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI.

Authors:  Peta Wood; Vishwaroop Mulay; Masoud Darabi; Karen Cecilia Chan; Joerg Heeren; Albert Pol; Gilles Lambert; Kerry-Anne Rye; Carlos Enrich; Thomas Grewal
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

7.  Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors.

Authors:  A Bordoni; M Di Nunzio; F Danesi; P L Biagi
Journal:  Genes Nutr       Date:  2006-06       Impact factor: 5.523

Review 8.  Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

Review 9.  PPAR delta: a dagger in the heart of the metabolic syndrome.

Authors:  Grant D Barish; Vihang A Narkar; Ronald M Evans
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

10.  Identification of novel trophoblast invasion-related genes: heme oxygenase-1 controls motility via peroxisome proliferator-activated receptor gamma.

Authors:  Martin Bilban; Peter Haslinger; Johanna Prast; Florian Klinglmüller; Thomas Woelfel; Sandra Haider; Alexander Sachs; Leo E Otterbein; Gernot Desoye; Ursula Hiden; Oswald Wagner; Martin Knöfler
Journal:  Endocrinology       Date:  2008-10-09       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.